Trials of a malaria drug that was touted by President Donald Trump for treating COVID-19 delivered inconclusive results in New York, according to the head of the research team.
There was not a “statistically significant difference” between patients who took hydroxychloroquine and those who did not, David Holtgrave, dean of the University at Albany School of Public Health, told ABC News.
During CNN’s coronavirus town hall on Thursday night, New York Gov. Andrew Cuomo backed that up, saying the drug “was not seen as a positive, not seen as a negative.”
